BackCadrenal Therapeutics Overview

Cadrenal Therapeutics Net Tangible Assets

Cadrenal Therapeutics's net tangible assets is $4.1M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$4.09M
4.82% YoYΔ $-207205.00 vs prior year quarter

Peer trimmed avg / median

Loading

Cadrenal Therapeutics Net Tangible Assets History

Loading

Cadrenal Therapeutics vs. peers: Net Tangible Assets Comparison

Loading

Cadrenal Therapeutics Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Cadrenal Therapeutics (CVKD) FAQ

As of the most recent data (June 2026), CVKD shows a net tangible assets of $4.1M. That compares with $4.3M in the prior-year period — down 4.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CVKD's net tangible assets is now $4.1M (was $4.3M) — a 4.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Cadrenal Therapeutics is outperforming or lagging.

Tracking CVKD's net tangible assets over time shows whether Cadrenal Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $4.1M That compares with $4.3M in the prior-year period — down 4.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Cadrenal Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $4.1M) with ownership activity and broader fundamentals.